LT2767292T - Palaikomosios vietinės anestezijos mišinys su saib - Google Patents

Palaikomosios vietinės anestezijos mišinys su saib

Info

Publication number
LT2767292T
LT2767292T LTEP14167954.8T LT14167954T LT2767292T LT 2767292 T LT2767292 T LT 2767292T LT 14167954 T LT14167954 T LT 14167954T LT 2767292 T LT2767292 T LT 2767292T
Authority
LT
Lithuania
Prior art keywords
composition containing
local anesthetic
sustained local
anesthetic composition
containing saib
Prior art date
Application number
LTEP14167954.8T
Other languages
English (en)
Inventor
Neil A Verity
Original Assignee
Durect Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Durect Corporation filed Critical Durect Corporation
Publication of LT2767292T publication Critical patent/LT2767292T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
LTEP14167954.8T 2004-09-17 2005-09-15 Palaikomosios vietinės anestezijos mišinys su saib LT2767292T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61079704P 2004-09-17 2004-09-17
US69139505P 2005-06-17 2005-06-17

Publications (1)

Publication Number Publication Date
LT2767292T true LT2767292T (lt) 2016-12-12

Family

ID=35949130

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14167954.8T LT2767292T (lt) 2004-09-17 2005-09-15 Palaikomosios vietinės anestezijos mišinys su saib

Country Status (26)

Country Link
US (9) US8753665B2 (lt)
EP (4) EP2767292B1 (lt)
JP (2) JP5285275B2 (lt)
KR (2) KR101492361B1 (lt)
AT (1) ATE537844T1 (lt)
AU (1) AU2005287175B2 (lt)
BR (1) BRPI0515372B8 (lt)
CA (1) CA2581287C (lt)
CY (2) CY1112625T1 (lt)
DK (3) DK1809329T3 (lt)
EA (2) EA014852B1 (lt)
ES (3) ES2378671T3 (lt)
GE (1) GEP20094831B (lt)
HK (1) HK1201437A1 (lt)
HR (1) HRP20120254T1 (lt)
HU (1) HUE032040T2 (lt)
IL (1) IL181474A (lt)
LT (1) LT2767292T (lt)
MX (1) MX2007002962A (lt)
NO (1) NO342596B1 (lt)
NZ (1) NZ553369A (lt)
PL (2) PL1809329T3 (lt)
PT (3) PT1809329E (lt)
RS (1) RS52198B (lt)
SI (2) SI2767292T1 (lt)
WO (1) WO2006033948A2 (lt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
DK1809329T3 (da) 2004-09-17 2012-04-02 Durect Corp Vedvarende lokalanæstesisammensætning indeholdende saib
US7906136B2 (en) * 2004-10-01 2011-03-15 Ramscor, Inc. Conveniently implantable sustained release drug compositions
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
ES2388355T3 (es) * 2006-11-03 2012-10-11 Durect Corporation Sistemas de suministro transdémico que comprenden bupivacaína
HUE043185T2 (hu) * 2007-03-28 2019-08-28 Innocoll Pharm Ltd Hatóanyag leadó eszköz helyi fájdalomcsillapításra, helyi érzéstelenítésre vagy idegblokkolásra
CA2714514C (en) * 2008-02-08 2016-08-16 Qps Llc Non-polymeric compositions for controlled drug delivery
US20100143437A1 (en) * 2008-12-09 2010-06-10 Morris Edward J Implantable analgesic
US9045600B2 (en) 2009-05-13 2015-06-02 Keraplast Technologies, Ltd. Biopolymer materials
AU2011336896B2 (en) * 2010-11-24 2015-12-24 Durect Corporation Biodegradable drug delivery composition
ES2689293T3 (es) * 2012-05-16 2018-11-13 Orexa B.V. Medio para facilitar la ingesta de alimentos y retención de los mismos
MX352907B (es) * 2013-03-15 2017-12-13 Heron Therapeutics Inc Composiciones de un poliortoéster y un solvente aprótico.
BR112015029144A2 (pt) * 2013-05-24 2017-07-25 Univ Danmarks Tekniske formulações de gel para guiar radioterapia
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
WO2015123734A1 (en) * 2014-02-21 2015-08-27 The University Of Sydney Liquid carrier materials
EP3509601A1 (en) 2014-04-21 2019-07-17 Heron Therapeutics, Inc. A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
MX2016013719A (es) 2014-04-21 2017-07-11 Heron Therapeutics Inc Sistemas de suministro polimerico de accion prolongada.
KR20170025011A (ko) 2015-08-27 2017-03-08 고려대학교 산학협력단 통증완화약물의 지속성 방출을 위한 약학적 조성물 및 그 투여를 위한 투여 장치
WO2017193066A1 (en) * 2016-05-05 2017-11-09 Liquidia Technologies, Inc. Precision controlled load and release particles for post-operative pain
US10682340B2 (en) 2016-06-30 2020-06-16 Durect Corporation Depot formulations
UA124768C2 (uk) 2016-06-30 2021-11-17 Дьюрект Корпорейшн Депо-препарат
EP3558279A4 (en) * 2016-12-26 2020-12-02 Cellix Bio Private Limited COMPOSITIONS AND PROCEDURES FOR TREATMENT OF CHRONIC PAIN
DK3486233T3 (da) * 2017-03-27 2021-03-15 Fruithy Holdings Ltd Dårligt opløseligt kompleks eller solvat deraf, farmaceutisk sammensætning og anvendelse deraf
CA3078555A1 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
RU2674025C1 (ru) * 2017-10-25 2018-12-04 Общество с ограниченной ответственностью "Научно-производственная фирма "ЭЛЕСТ" (ООО "НПФ "ЭЛЕСТ") Лекарственное средство на основе порфиринового фотосенсибилизатора копропорфирина для лечения рака кожи методом фотодинамической терапии
EP4087540A4 (en) * 2020-01-06 2024-01-10 Pacira Pharmaceuticals Inc TREATMENT OF PAIN ASSOCIATED WITH CESAREON SECTION USING SUSTAINED RELEASE LIPOSOMAL ANESTHETICS COMPOSITION
EP4087554A4 (en) 2020-01-10 2024-01-17 Pacira Pharmaceuticals Inc TREATMENT OF PAIN BY SUBARACHNOID ADMINISTRATION OF SUSTAINED-RELEASE LIPOSOMAL ANESTHETICAL COMPOSITIONS
WO2021141959A1 (en) 2020-01-10 2021-07-15 Pacira Pharmaceuticals, Inc. Treatment of pain by administration of sustained-release liposomal anesthetic compositions
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
AU2021227897A1 (en) * 2020-02-25 2022-09-15 The University Of North Carolina At Chapel Hill Eutectic based anesthetic compositions and applications thereof
BR112023013685A2 (pt) 2021-01-11 2023-11-14 Pacira Pharmaceuticals Inc Tratamento da dor no quadril com composições anestésicas lipossômicas de liberação sustentada
CN115068414B (zh) * 2021-03-16 2023-07-21 湖南慧泽生物医药科技有限公司 供注射用罗哌卡因长效溶液制剂及其制备方法
BR112023018896A2 (pt) 2021-03-19 2023-10-10 Pacira Pharmaceuticals Inc Tratamento da dor em pacientes pediátricos por administração de composições anestésicas lipossômicas de liberação prolongada
CN115414324A (zh) * 2021-05-31 2022-12-02 中国科学院过程工程研究所 一种载局部麻醉药的乳剂及其制备方法
US11918572B2 (en) 2022-01-28 2024-03-05 Rebel Medicine Inc Pharmaceutical compositions for treating pain
US11918565B1 (en) 2022-11-03 2024-03-05 Pacira Pharmaceuticals, Inc. Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US556450A (en) * 1896-03-17 Antifriction-bearing
US2931802A (en) 1958-04-30 1960-04-05 Eastman Kodak Co Mixed esters of glucose and sucrose
GB1088992A (en) 1963-09-19 1967-10-25 Squibb & Sons Inc Protective dressings
US4411890A (en) 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
US3743398A (en) * 1971-03-22 1973-07-03 Eastman Kodak Co Motion picture projector
NO139560C (no) 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
IE40257B1 (en) 1973-11-01 1979-04-25 Wellcome Found Nona- and decapeptide amides
DE2438350C3 (de) * 1974-08-09 1979-06-13 Hoechst Ag, 6000 Frankfurt Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2438352A1 (de) 1974-08-09 1976-02-26 Hoechst Ag Peptidcyclopropylamide mit lh-rh/fshrh-wirkung
GB1524747A (en) * 1976-05-11 1978-09-13 Ici Ltd Polypeptide
US4360019A (en) 1979-02-28 1982-11-23 Andros Incorporated Implantable infusion device
JPS55154991A (en) * 1979-05-23 1980-12-02 Hisamitsu Pharmaceut Co Inc Beta-d-fructopyranoside derivative
NZ194405A (en) * 1979-08-02 1982-05-25 Dut Pty Ltd Producing liquid hydrocarbon streams by hydrogenation of fossil-based feedstock
US4692147A (en) * 1980-04-02 1987-09-08 Medtronic, Inc. Drug administration device
IE52535B1 (en) 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
US4530840A (en) 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
DE3716302C2 (de) 1987-05-15 1996-02-01 Henkel Kgaa Verbesserte resorbierbare Knochenwachse und ihre Verwendung
US4906474A (en) 1983-03-22 1990-03-06 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
JPS59210024A (ja) 1983-05-13 1984-11-28 Taiyo Kagaku Kk トコフエロ−ル乳化物
US4725442A (en) 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPS607418U (ja) 1983-06-28 1985-01-19 株式会社デンソー 歯付スラストワツシヤをもつ軸受装置
US4891225A (en) 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4630019A (en) 1984-09-28 1986-12-16 Westinghouse Electric Corp. Molded case circuit breaker with calibration adjusting means for a bimetal
US4725852A (en) * 1985-05-09 1988-02-16 Burlington Industries, Inc. Random artificially perturbed liquid apparatus and method
US4780320A (en) 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
US4970075A (en) 1986-07-18 1990-11-13 Euroceltique, S.A. Controlled release bases for pharmaceuticals
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5234520A (en) 1987-03-20 1993-08-10 Morgan Adhesives Co. Method of making an adhesive construction
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US4795641A (en) * 1987-08-20 1989-01-03 Eastman Kodak Company Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
US5350741A (en) * 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
US5702716A (en) 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US4987893A (en) 1988-10-12 1991-01-29 Rochal Industries, Inc. Conformable bandage and coating material
US5324520A (en) * 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
US5324519A (en) 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
GB8926612D0 (en) 1989-11-24 1990-01-17 Erba Farmitalia Pharmaceutical compositions
IT1240643B (it) 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
US5110685A (en) 1990-05-18 1992-05-05 Exxon Chemical Patents, Inc. Low friction, abrasion resistant polymer coating
US5149543A (en) 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
WO1992017900A1 (en) 1991-04-03 1992-10-15 Eastman Kodak Company HIGH DURABILITY MASK FOR DRY ETCHING OF GaAs
JP3313124B2 (ja) * 1991-07-31 2002-08-12 森下仁丹株式会社 親水性物質を内容物とするシームレスカプセルおよびその製法
US5487898A (en) * 1991-08-26 1996-01-30 Abbott Laboratories Compositions and method for the sublingual or buccal administration therapeutic agents
KR100256715B1 (ko) 1991-08-26 2000-05-15 스티븐 에프. 웨인스톡 치료제의 설하 또는 구강 투여를 위한 조성물
IL103275A0 (en) 1991-10-01 1993-02-21 Lilly Co Eli Injectable extended release formulations and methods
YU87892A (sh) 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
AU2605592A (en) 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
EP0609345B1 (en) * 1991-10-21 1999-09-22 Peptech Limited Biocompatible implant for the timing of ovulation in mares
US5266331A (en) 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5656295A (en) * 1991-11-27 1997-08-12 Euro-Celtique, S.A. Controlled release oxycodone compositions
AU3125193A (en) 1991-12-05 1993-06-28 Pitman-Moore, Inc. A carbohydrate glass matrix for the sustained release of a therapeutic agent
WO1993011754A1 (en) * 1991-12-11 1993-06-24 The Procter & Gamble Company Cetylpyridinium chloride and domiphen bromide in organic solvent
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
WO1993019739A1 (en) * 1992-03-30 1993-10-14 Alza Corporation Viscous suspensions of controlled-release drug particles
ATE210969T1 (de) 1992-09-10 2002-01-15 Childrens Medical Center Biodegradierbare polymeren matrizen mit verzoegerter freisetzung von lokalanaesthetika
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
EP0678018B1 (en) 1993-01-06 2003-04-09 Kinerton Limited Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
AU679510B2 (en) * 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing a diol-diacid derived dispersing aid
WO1994021229A1 (en) 1993-03-17 1994-09-29 Minnesota Mining And Manufacturing Company Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid
DK44193D0 (da) 1993-04-20 1993-04-20 Euromed I S Saarforbinding og klaebemiddel til en saarforbinding eller lignende
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
JP3257750B2 (ja) 1993-07-20 2002-02-18 エチコン・インコーポレーテツド ε−カプロラクトンおよびラクチドの液状コポリマー
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
TW282403B (lt) * 1993-08-26 1996-08-01 Takeda Pharm Industry Co Ltd
WO1995009613A1 (en) 1993-10-04 1995-04-13 Mark Chasin Controlled release microspheres
DE69431071T2 (de) 1993-12-29 2003-03-20 Matrix Pharma Zusammensetzung für lokale freigabe von zytostatika
DE69534780T2 (de) * 1994-04-08 2006-10-05 Qlt Usa Inc., Fort Collins Flüssige Zusammensetzungen zur Arzneistoffabgabe
US5633000A (en) * 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
PL183204B1 (pl) 1994-09-23 2002-06-28 Darwin Discovery Ltd Sposób racemizacji optycznie wzbogaconej bupiwakainy
US5599852A (en) 1994-10-18 1997-02-04 Ethicon, Inc. Injectable microdispersions for soft tissue repair and augmentation
PL183210B1 (pl) 1994-10-25 2002-06-28 Darwin Discovery Ltd Sposób wytwarzania wzbogaconej optycznie bupiwakainy
ATE248148T1 (de) 1994-10-25 2003-09-15 Darwin Discovery Ltd Verfahren zur herstellung von levobupivacaine und analoge
GB9501071D0 (en) 1995-01-18 1995-03-08 Chiroscience Ltd Racemisation
US6384227B2 (en) * 1995-01-18 2002-05-07 Darwin Discovery Ltd. Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
US6413536B1 (en) * 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5968542A (en) 1995-06-07 1999-10-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system as a device
JP4330175B2 (ja) 1995-06-07 2009-09-16 デュレクト コーポレイション 高粘度液体による制御された送達系
ATE267587T1 (de) 1995-06-09 2004-06-15 Euro Celtique Sa Formulierungen und verfahren für eine verlängerte lokalanästhesie
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
ES2246004T3 (es) 1996-02-02 2006-02-01 Alza Corporation Liberacion prolongada de un agente activo usando un sistema implantable.
US6245351B1 (en) * 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
JPH11511763A (ja) 1996-06-24 1999-10-12 ユーロ―セルティーク，エス．エイ． 安全な局所麻酔の提供方法
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
US6046187A (en) * 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US5747051A (en) * 1996-09-27 1998-05-05 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
US6572880B2 (en) 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6479074B2 (en) 1996-10-24 2002-11-12 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6331311B1 (en) 1996-12-20 2001-12-18 Alza Corporation Injectable depot gel composition and method of preparing the composition
US6203813B1 (en) * 1997-01-13 2001-03-20 Lance L. Gooberman Pharmaceutical delivery device and method of preparation therefor
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
DE19714765A1 (de) 1997-04-10 1998-10-15 Merck Patent Gmbh Verwendung von niedermolekularen, oligomeren Estern von alpha-Hydroxysäuren und/oder aromatischen o-Hydroxysäuren in kosmetischen Formulierungen
US5919473A (en) * 1997-05-12 1999-07-06 Elkhoury; George F. Methods and devices for delivering opioid analgesics to wounds via a subdermal implant
US5840329A (en) 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
DE69818675T2 (de) 1997-07-29 2004-07-29 Alcon Laboratories, Inc., Fort Worth Galaktomannanpolymere und borat enthaltende augenarzneimittel
PT1032390E (pt) 1997-11-19 2004-04-30 Darwin Discovery Ltd Formulacao anestesica
RU2180557C2 (ru) * 1998-06-26 2002-03-20 Казахский Государственный национальный университет им. Аль-Фараби Анестезирующий состав пролонгированного действия
HUP0102728A3 (en) 1998-06-29 2002-12-28 Pharmaceuticals Applic Associa Methods and transdermal compositions for pain relief
US6312717B1 (en) 1998-07-07 2001-11-06 Bristol-Myers Squibb Company Method for treatment of anxiety and depression
DE19858891A1 (de) 1998-12-19 2000-06-21 Merck Patent Gmbh Verbesserte Knochensiegel
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
CA2375371A1 (en) * 1999-06-04 2000-12-14 Skyepharma Inc. Oil-core compositions for the sustained release of hydrophobic drugs
WO2000078335A1 (en) 1999-06-18 2000-12-28 Southern Biosystems, Inc. COMPOSITIONS FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS
EE200200357A (et) * 1999-12-23 2003-10-15 Pfizer Products Inc. Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
WO2001051024A2 (de) 2000-01-11 2001-07-19 Roland Bodmeier Kit zur implantation enthaltend eine trägerphase und ein lösemittel
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
CA2406790C (en) * 2000-04-19 2009-07-07 Genentech, Inc. Sustained release formulations
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
WO2002010436A2 (en) 2000-07-28 2002-02-07 The Brigham And Women's Hospital, Inc. Prognostic classification of breast cancer
FR2814308B1 (fr) * 2000-09-15 2003-03-14 France Telecom Procede de gestion de l'usage d'une ligne de telecommunication et systeme de mise en oeuvre
KR101167465B1 (ko) * 2000-10-30 2012-07-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
JP2004521111A (ja) * 2001-01-25 2004-07-15 ユーロ−セルティーク，エス．エイ． 局所麻酔薬および使用法
AU2002320122B2 (en) 2001-06-21 2007-07-26 Genentech, Inc. Sustained release formulation
WO2003041684A2 (en) * 2001-11-14 2003-05-22 Alza Corporation Injectable depot compositions and uses thereof
FR2838349B1 (fr) 2002-04-15 2004-06-25 Laurence Paris Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication
EP1509182A4 (en) 2002-05-31 2009-12-30 Titan Pharmaceuticals Inc IMPLANTABLE POLYMERS DEVICE FOR THE DELAYED RELEASE OF BUPRENORPHINE
US20040109893A1 (en) * 2002-06-25 2004-06-10 Guohua Chen Sustained release dosage forms of anesthetics for pain management
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
JP4417039B2 (ja) 2002-06-28 2010-02-17 太陽化学株式会社 水中油滴型乳化組成物
JP4712380B2 (ja) 2002-07-26 2011-06-29 三笠製薬株式会社 外用剤
PL375603A1 (en) 2002-10-25 2005-12-12 Pfizer Products Inc. Depot formulations of arylheterocyclic active agents in the form of a suspension
AU2003267788A1 (en) * 2002-10-25 2004-05-13 Pfizer Products Inc. Novel injectable depot formulations
HUE026034T2 (en) * 2002-12-13 2016-05-30 Durect Corp Oral delivery system containing an oral high-viscosity carrier
BR0317421A (pt) 2002-12-19 2005-11-08 Alza Corp Géis de fase única não-aquosa estável e formulações destes para liberação a partir de um dispositivo implantável
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10322469A1 (de) 2003-05-19 2004-12-16 Bayer Healthcare Ag Heterocyclische Verbindungen
WO2005048742A1 (en) * 2003-11-14 2005-06-02 Eastman Chemical Company Sucrose acetate isobutyrate formulation
US20050106304A1 (en) 2003-11-14 2005-05-19 Cook Phillip M. Sucrose acetate isobutyrate formulation
US20050232876A1 (en) 2004-04-19 2005-10-20 Robin Lynn Minga Skin care compositions
WO2005111993A1 (ja) * 2004-05-14 2005-11-24 Yanmar Co., Ltd. キャビンの制音構造
US20050266087A1 (en) 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
DK1809329T3 (da) 2004-09-17 2012-04-02 Durect Corp Vedvarende lokalanæstesisammensætning indeholdende saib
US20060263433A1 (en) 2005-02-03 2006-11-23 Ayer Rupal A Suspension formulation of interferon
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP5194273B2 (ja) 2007-09-20 2013-05-08 三菱電機株式会社 半導体装置
SE531980C2 (sv) 2008-01-17 2009-09-22 Avtech Sweden Ab Flygstyrningsförfarande samt datorprogram och datorprogramprodukt för att genomföra förfarandet

Also Published As

Publication number Publication date
EP1809329B1 (en) 2011-12-21
EP1809329A2 (en) 2007-07-25
EP2767292B1 (en) 2016-08-24
HRP20120254T1 (hr) 2012-04-30
ES2378671T3 (es) 2012-04-16
ATE537844T1 (de) 2012-01-15
EP2415484B1 (en) 2014-06-18
IL181474A (en) 2014-05-28
PT1809329E (pt) 2012-03-29
WO2006033948A2 (en) 2006-03-30
US8753665B2 (en) 2014-06-17
EA201001885A1 (ru) 2011-12-30
US20090036490A1 (en) 2009-02-05
AU2005287175A1 (en) 2006-03-30
JP2008513467A (ja) 2008-05-01
EA200700653A1 (ru) 2007-10-26
US20160235726A1 (en) 2016-08-18
CA2581287A1 (en) 2006-03-30
KR101492361B1 (ko) 2015-02-11
EA014852B1 (ru) 2011-02-28
AU2005287175B2 (en) 2011-12-01
JP5285374B2 (ja) 2013-09-11
HUE032040T2 (en) 2017-09-28
US20190231762A1 (en) 2019-08-01
SI2415484T1 (sl) 2014-10-30
HK1201437A1 (en) 2015-09-04
EP3103477A1 (en) 2016-12-14
NO342596B1 (no) 2018-06-18
MX2007002962A (es) 2008-03-05
RS52198B (en) 2012-10-31
DK2767292T3 (en) 2016-12-19
CY1112625T1 (el) 2016-02-10
CA2581287C (en) 2015-08-25
NO20071914L (no) 2007-06-15
DK1809329T3 (da) 2012-04-02
EP2415484A1 (en) 2012-02-08
IL181474A0 (en) 2007-07-04
CY1118360T1 (el) 2017-06-28
US20170216267A1 (en) 2017-08-03
SI2767292T1 (sl) 2017-01-31
JP5285275B2 (ja) 2013-09-11
BRPI0515372B8 (pt) 2021-05-25
PT2415484E (pt) 2014-09-19
JP2009073839A (ja) 2009-04-09
ES2602273T3 (es) 2017-02-20
US20080167630A1 (en) 2008-07-10
US8153661B2 (en) 2012-04-10
PL2415484T3 (pl) 2014-11-28
PL1809329T3 (pl) 2012-08-31
US20130289069A1 (en) 2013-10-31
EP2767292A1 (en) 2014-08-20
BRPI0515372A (pt) 2008-07-22
US8153149B2 (en) 2012-04-10
DK2415484T3 (da) 2014-09-22
GEP20094831B (en) 2009-11-25
BRPI0515372B1 (pt) 2020-10-06
ES2496765T3 (es) 2014-09-19
KR101351771B1 (ko) 2014-02-17
US20150111924A1 (en) 2015-04-23
US20180256553A1 (en) 2018-09-13
US20110009451A1 (en) 2011-01-13
US8846072B2 (en) 2014-09-30
WO2006033948A3 (en) 2006-06-08
KR20070059148A (ko) 2007-06-11
NZ553369A (en) 2010-11-26
PT2767292T (pt) 2016-11-23
KR20130136595A (ko) 2013-12-12

Similar Documents

Publication Publication Date Title
HK1201437A1 (en) Sustained local anesthetic composition containing saib saib
MX2009010289A (es) Composiciones para administracion nasal.
WO2005112633A3 (en) Compounds and compositions for delivering active agents
TW200800967A (en) Benzimidazole thiophene compounds
IL193024A0 (en) Levetiracetam formulations and methods for their manufacture
HK1154777A1 (en) Lipoprotein lipase-activating compositions comprising benzene derivatives
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX2010004487A (es) Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular.
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
NO20064808L (no) Orale matrixformuleringer med licarbazepin
WO2007133944A3 (en) Topical administration of acyclovir
BRPI0509014A (pt) comprimidos desintegráveis que compreendem licarbazepina
WO2007121471A3 (en) Dialkyl ether delivery agents
MX2008002272A (es) Compuestos de ciclopropilo y composiciones para suministrar agentes activos.
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
EP1852119A4 (en) PHARMACEUTICAL PREPARATION CONTAINING PHENOXAZINIUM DERIVATIVE AS ACTIVE INGREDIENT
WO2006076569A3 (en) Bicyclic heterocycles as cannabinoid receptor modulators
WO2006076598A3 (en) Bicyclic heterocycles as cannabinoid receptor modulators
UA102403C2 (ru) Композиция для перорального введения
TW200642686A (en) Aporphine or secoaporphine compounds for treatment of diabetes
HK1104790A1 (en) Pharmaceutical formulations of fenofibrate having improved bioavailability
TW200731964A (en) Pharmaceutical formulations of fenofibrate having improved bioavailability
MXNL06000098A (es) Compuesto como antagonistas de ccr5.